Sigma-2 receptor binding is decreased in female, but not male, APP/PS1 mice

Biochemical and Biophysical Research Communications

Volumn 460, Issue 2, 2015, Pages 439-445

  Sahlholm, Kristoffer ^a   Liao, Fan ^a   Holtzman, David M ^a   Xu, Jinbin ^a   Mach, Robert H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Peripheral benzodiazepine receptor; PGRMC1; Sigma 2 receptor; Transgenic mice

Indexed keywords

PROTEIN BINDING; SIGMA OPIATE RECEPTOR; SIGMA-2 RECEPTOR;

AMYLOID PLAQUE; ANIMAL; AUTORADIOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MOUSE; RADIOASSAY; SEX DIFFERENCE;

ANIMALS; AUTORADIOGRAPHY; FEMALE; HUMANS; MALE; MICE; PLAQUE, AMYLOID; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, SIGMA; SEX FACTORS;

EID: 84937758243     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.052     Document Type: Article

References (34)

1. J.R. Petrella Neuroimaging and the search for a cure for Alzheimer disease Radiology 269 2013 671 691
2. L. Mucke, and D.J. Selkoe Neurotoxicity of amyloid β-protein: synaptic and network dysfunction Cold Spring Harb. Perspect. Med. 2 2012 a006338
3. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
4. K. Andersen, L.J. Launer, M.E. Dewey, L. Letenneur, A. Ott, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, M. Baldereschi, C. Brayne, A. Lobo, J.M. Martinez-Lage, T. Stijnen, and A. Hofman Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group Neurology 53 1999 1992 1997
5. A.M. Barron, and C.J. Pike Sex hormones, aging, and Alzheimer's disease Front. Biosci. (Elite Ed.) 4 2012 976 997
6. M. Singh, and C. Su Progesterone and neuroprotection Horm. Behav. 63 2013 284 290
7. J.C. Carroll, E.R. Rosario, A. Villamagna, and C.J. Pike Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice Endocrinology 151 2010 2713 2722
8. C.A. Frye, and A.A. Walf Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice Neurobiol. Learn. Mem. 89 2008 17 26
9. M. Johannessen, D. Fontanilla, T. Mavlyutov, A.E. Ruoho, and M.B. Jackson Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels Am. J. Physiol. Cell. Physiol. 300 2011 C328 C337
10. J. Xu, C. Zeng, W. Chu, F. Pan, J.M. Rothfuss, F. Zhang, Z. Tu, D. Zhou, D. Zeng, S. Vangveravong, F. Johnston, D. Spitzer, K.C. Chang, R.S. Hotchkiss, W.G. Hawkins, K.T. Wheeler, and R.H. Mach Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site Nat. Commun. 2 2011 380
11. L. Liu, J. Wang, L. Zhao, J. Nilsen, K. McClure, K. Wong, and R.D. Brinton Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2 Endocrinology 150 2009 3186 3196
12. N.J. Izzo, A. Staniszewski, L. To, M. Fa, A.F. Teich, F. Saeed, H. Wostein, T. Walko 3rd, A. Vaswani, M. Wardius, Z. Syed, J. Ravenscroft, K. Mozzoni, C. Silky, C. Rehak, R. Yurko, P. Finn, G. Look, G. Rishton, H. Safferstein, M. Miller, C. Johanson, E. Stopa, M. Windisch, B. Hutter-Paier, M. Shamloo, O. Arancio, H. LeVine 3rd, and S.M. Catalano Alzheimer's therapeutics targeting amyloid Beta 1-42 oligomers I: abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits PLoS One 9 2014 e111898
13. N.J. Izzo, J. Xu, C. Zeng, M.J. Kirk, K. Mozzoni, C. Silky, C. Rehak, R. Yurko, G. Look, G. Rishton, H. Safferstein, C. Cruchaga, A. Goate, M.A. Cahill, O. Arancio, R.H. Mach, R. Craven, E. Head, H. LeVine 3rd, T.L. Spires-Jones, and S.M. Catalano Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: sigma-2/PGRMC1 receptors mediate abeta 42 oligomer binding and synaptotoxicity PLoS One 9 2014 e111899
14. A.A. Behensky, I.E. Yasny, A.M. Shuster, S.B. Seredenin, A.V. Petrov, and J. Cuevas Stimulation of sigma receptors with Afobazole blocks activation of microglia and reduces Toxicity caused by amyloid-β25-35 J. Pharmacol. Exp. Ther. 347 2013 458 467
15. A. Savonenko, G.M. Xu, T. Melnikova, J.L. Morton, V. Gonzales, M.P. Wong, D.L. Price, F. Tang, A.L. Markowska, and D.R. Borchelt Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to β-amyloid deposition and neurotransmitter abnormalities Neurobiol. Dis. 18 2005 602 617
16. A. Cagnin, D.J. Brooks, A.M. Kennedy, R.N. Gunn, R. Myers, F.E. Turkheimer, T. Jones, and R.B. Banati In-vivo measurement of activated microglia in dementia Lancet 358 2001 461 467
17. F. Yasuno, M. Ota, J. Kosaka, H. Ito, M. Higuchi, T.K. Doronbekov, S. Nozaki, Y. Fujimura, M. Koeda, T. Asada, and T. Suhara Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106 Biol. Psychiatry 64 2008 835 841
18. B. Gulyás, B. Makkai, P. Kása, K. Gulya, L. Bakota, S. Várszegi, Z. Beliczai, J. Andersson, L. Csiba, A. Thiele, T. Dyrks, T. Suhara, K. Suzuki, M. Higuchi, and C. Halldin A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system Neurochem. Int. 54 2009 28 36
19. J.S. Rao, M. Kellom, H.W. Kim, S.I. Rapoport, and E.A. Reese Neuroinflammation and synaptic loss Neurochem. Res. 37 2012 903 910
20. Z. Tu, C.S. Dence, D.E. Ponde, L. Jones, K.T. Wheeler, M.J. Welch, and R.H. Mach Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer Nucl. Med. Biol. 32 2005 423 430
21. J. Perregaard, E.K. Moltzen, E. Meier, and C. Sanchez Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles J. Med. Chem. 38 1995 1998 2008
22. J. Xu, B. Hassanzadeh, W. Chu, Z. Tu, L.A. Jones, R.R. Luedtke, J.S. Perlmutter, M.A. Mintun, and R.H. Mach [3H]4-(Dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D3 receptors. II. Quantitative analysis of dopamine D3 and D2 receptor density ratio in the caudate-putamen Synapse 64 2010 449 459
23. J. Kim, J.M. Castellano, H. Jiang, J.M. Basak, M. Parsadanian, V. Pham, S.M. Mason, S.M. Paul, and D.M. Holtzman Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance Neuron 64 2009 632 644
24. J. Xu, Z. Tu, L.A. Jones, S. Vangveravong, K.T. Wheeler, and R.M. Mach [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe Eur. J. Pharmacol. 525 2005 8 17
25. K.K. Søby, J.D. Mikkelsen, E. Meier, and C. Thomsen Lu 28-179 labels a sigma(2)-site in rat and human brain Neuropharmacology 43 2002 95 100
26. C. Abate, S.V. Selivanova, A. Müller, S.D. Krämer, R. Schibli, R. Marottoli, R. Perrone, F. Berardi, M. Niso, and S.M. Ametamey Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ receptors Eur. J. Med. Chem. 69 2013 920 930
27. K.A. Intlekofer, and S.L. Petersen Distribution of mRNAs encoding classical progestin receptor, progesterone membrane components 1 and 2, serpine mRNA binding protein 1, and progestin and ADIPOQ receptor family members 7 and 8 in rat forebrain Neuroscience 172 2011 55 65
28. E. Briard, J. Hong, J.L. Musachio, S.S. Zoghbi, M. Fujita, M. Imaizumi, V. Cropley, R.B. Innis, and V.W. Pike Synthesis and evaluation of two candidate 11C-labeled radioligands for brain peripheral benzodiazepine receptors J. Label. Compd. Radiopharm. 48 2005 S71
29. D. Meffre, B. Delespierre, M. Gouézou, P. Leclerc, G.P. Vinson, M. Schumacher, D.G. Stein, and R. Guennoun The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury J. Neurochem. 93 2005 1314 1326
30. C.J. Krebs, E.D. Jarvis, J. Chan, J.P. Lydon, S. Ogawa, and D.W. Pfaff A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors Proc. Natl. Acad. Sci. U S A. 97 2000 12816 12821
31. H. Sakamoto, K. Ukena, H. Takemori, M. Okamoto, M. Kawata, and K. Tsutsui Expression and localization of 25-Dx, a membrane-associated putative progesterone-binding protein, in the developing Purkinje cell Neuroscience 126 2004 325 334
32. N. Bali, T.E. Morgan, and C.E. Finch Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradiol-dependent neurite sprouting and in microglial activation Front. Neurosci. 7 2013 157
33. B. Ji, J. Maeda, M. Sawada, M. Ono, T. Okauchi, M. Inaji, M.R. Zhang, K. Suzuki, K. Ando, M. Staufenbiel, J.Q. Trojanowski, V.M. Lee, M. Higuchi, and T. Suhara Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies J. Neurosci. 28 2008 12255 12267
34. S.K. Bengtsson, M. Johansson, T. Bäckström, and M.J. Wang Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice Alzheimers Dis. 31 2012 71 84